Hot Features
Premium
Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Período:
Tipo de Línea:
| Volume | 9,804,173 |
|
|||||
| Noticias | - | ||||||
| Máximo del Dia | 1,799.50 | Mínimo Máximo |
|||||
| Minimo del Dia | 1,780.00 | ||||||
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| Gsk Plc | GSK | London | Acción Ordinaria |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| 19.00 | 1.07% | 1,799.50 | 10:35:21 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 1,784.00 | 1,780.00 | 1,799.50 | 1,799.50 | 1,780.50 |
| Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
|---|---|---|---|---|---|
| 6,160 | 9,804,173 | 1,797.07p | 176,187,469p | - | 1,302.60 - 1,799.50 |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| 11:21:20 | O | 4,618,215 | 1,784.00p | GBX |
| Sector Industrial de la empresa |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
Información Financiera Gsk Plc GSK
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 73.94B | 4.12B | - | 30.33B | 4.93B | 1.20 | 15.00 |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre Gsk Plc GSK
| Fecha | Hora | Fuente | Noticias Artículo |
|---|---|---|---|
| 08/5/2024 | 12:21 | RNS Regulatory News | GSK PLC Result of AGM |
| 08/5/2024 | 10:57 | RNS Regulatory News | GSK PLC Board Committee Change |
| 07/5/2024 | 00:00 | GlobeNewswire Inc. | BioVersys Announces Expansion of Strategic Collaboration.. |
| 03/5/2024 | 09:30 | RNS Regulatory News | GSK PLC Director/PDMR Shareholding |
| 01/5/2024 | 09:00 | RNS Regulatory News | GSK PLC Total Voting Rights |
| 01/5/2024 | 02:50 | Alliance News |  TOP NEWS: GSK expects momentum to continue after strong.. |
| 01/5/2024 | 01:00 | RNS Regulatory News | GSK PLC 1st Quarter Results |
| 24/4/2024 | 03:14 | Alliance News | GSK's Jemperli with chemotherapy accepted for priority.. |
| 24/4/2024 | 01:00 | RNS Regulatory News | GSK PLC US FDA accepts new indication filing for Jemperli |
| 19/4/2024 | 09:30 | RNS Regulatory News | GSK PLC Director/PDMR Shareholding |
| 17/4/2024 | 09:30 | RNS Regulatory News | GSK PLC Director/PDMR Shareholding |
| 17/4/2024 | 02:46 | Alliance News | TOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea.. |
Histórico de Datos GSK
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1,733.00 | 1,799.50 | 1,724.50 | 1,763.49 | 7,387,028 | 66.50 | 3.84% |
| 1 Month | 1,631.50 | 1,799.50 | 1,575.00 | 1,673.88 | 6,159,377 | 168.00 | 10.30% |
| 3 Months | 1,662.00 | 1,799.50 | 1,575.00 | 1,669.53 | 7,603,035 | 137.50 | 8.27% |
| 6 Months | 1,412.80 | 1,799.50 | 1,379.60 | 1,586.94 | 7,676,186 | 386.70 | 27.37% |
| 1 Year | 1,439.60 | 1,799.50 | 1,302.60 | 1,502.54 | 7,431,341 | 359.90 | 25.00% |
| 3 Years | 1,355.00 | 1,824.40 | 1,283.20 | 1,514.21 | 8,558,941 | 444.50 | 32.80% |
| 5 Years | 1,520.80 | 1,857.00 | 1,190.80 | 1,525.67 | 8,870,453 | 278.70 | 18.33% |
